Patents by Inventor James Stubstad

James Stubstad has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical composition
    Patent number: 6255284
    Abstract: Polypeptide pharmaceutical compositions having improved stability and resistance to aggregation, particle formation and precipitation comprising a polypeptide pharmaceutical and poloxamer surfactants alone, or in combination with polysorbate surfactants. Preferred polypeptides stabilized are bactericidal/permeability increasing (BPI) protein, biologically active fragments of BPI, biologically active analogs of BPI, and biologically active variants of BPI.
    Type: Grant
    Filed: February 11, 2000
    Date of Patent: July 3, 2001
    Assignee: Xoma Corporation
    Inventors: Weldon Courtney McGregor, James Stubstad, C. Paul Chang
  • Pharmaceutical compositions of bactericidal/permeability increasing protein (BPI)
    Patent number: 6066620
    Abstract: Polypeptide pharmaceutical compositions having improved stability and resistance to aggregation, particle formation and precipitation comprising a polypeptide pharmaceutical and poloxamer surfactants alone, or in combination with polysorbate surfactants. Preferred polypeptides stabilized are bactericidal/permeability increasing (BPI) protein, biologically active fragments of BPI, biologically active analogs of BPI, and biologically active variants of BPI.
    Type: Grant
    Filed: May 17, 1999
    Date of Patent: May 23, 2000
    Assignee: Xoma Corporation
    Inventors: Weldon Courtney McGregor, James Stubstad, C. Paul Chang
  • Pharmaceutical composition
    Patent number: 5955427
    Abstract: Polypeptide pharmaceutical compositions having improved stability and resistance to aggregation, particle formation and precipitation comprising a polypeptide pharmaceutical and poloxamer surfactants alone, or in combination with polysorbate surfactants. Preferred polypeptides stabilized are bactericidal/permeability increasing (BPI) protein, biologically active fragments of BPI, biologically active analogs of BPI, and biologically active variants of BPI.
    Type: Grant
    Filed: December 8, 1997
    Date of Patent: September 21, 1999
    Assignee: XOMA Corporation
    Inventors: Weldon Courtney McGregor, James Stubstad, C. Paul Chang
  • Pharmaceutical composition
    Patent number: 5696090
    Abstract: Polypeptide pharmaceutical compositions having improved stability and resistance to aggregation, particle formation and precipitation comprising a polypeptide pharmaceutical and poloxamer surfactants alone, or in combination with polysorbate surfactants. Preferred polypeptides stabilized are bactericidal/permeability increasing (BPI) protein, biologically active fragments of BPI, biologically active analogs of BPI, and biologically active variants of BPI.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: December 9, 1997
    Assignee: Xoma Corporation
    Inventors: Weldon Courtney McGregor, James Stubstad, C. Paul Chang
  • Pharmaceutical composition comprising BPI proteins
    Patent number: 5488034
    Abstract: Bactericidal/permeability increasing (BPI) polypeptide pharmaceutical compositions having improved stability and resistance to aggregation, particle formation and precipitation comprising the polypeptide pharmaceutical and poloxamer surfactants alone, or in combination with polysorbate suractants. Preferred BPI polypeptides stabilized are bactericidal/permeability increasing (BPI) protein, biologically active fragments of BPI, and biologically active analogs of BPI.
    Type: Grant
    Filed: February 2, 1994
    Date of Patent: January 30, 1996
    Assignee: XOMA Corporation
    Inventors: Weldon C. McGregor, James Stubstad, C. Paul Chang